Trial intelligence / Profile preview

Iron Amino Acid Chelate for Anemia Prevention in Twin Gestations

NCT02858505Phase 2Completed

Sponsor
Assiut University
Start
Aug 2015
Primary completion
Jul 2016
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 2, randomised trial of ferrous bisglycinate in iron deficiency anemia (IDA) (2 arms), sponsored by Assiut University. Primary endpoint: Hemoglobin level at 24 weeks. Started Aug 2015; status: completed.

02

Drugs

ferrous bisglycinate
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on NCT02858505.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02858505.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call